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Background: In this pilot study, we evaluated the postoperative analgesic effect of 
the new lamina thoracic paravertebral block using a single-shot technique for 
major breast cancer surgery. 
Methods: A retrospective observational design was used to compare data involving 
16 consecutive ASA 1 and 2 female patients who had unilateral modified radical 
mastectomy with axillary clearance under general anaesthesia with paravertebral 
block and 15 others without block between 13/03/2014 to 12/05/2015. We 
compared the time to the first request for analgesic, total analgesic (opioid and 
non-opioid) consumption (in mg) and postoperative pain scores over 72 h between 
the two groups. 
Results: One patient was excluded from the cohort due to block failure. The median 
time to first request for analgesic was 43 h (25.2-73.0 h) in the block group versus 2 
h (1.0-2.5 h), p=0001. The pain scores was significantly lower at all measurement 
points among the block patients compared with the no-block group until 24 h 
postoperatively. No patient in the block group required analgesic within 24 h after 
surgery. The total consumption of pentazocine was nil (block group) vs. 154.0±74.2 
(range 90-300) mg, p=0.0000001. 
Conclusions: Single-shot lamina paravertebral block provided prolonged 
postoperative analgesia and reduced opioid and non-opioid consumption. 
Introduction 
Modified radical mastectomy with axillary clearance is the preferred surgical treatment 
of breast cancer in many parts of the world.1 However, effective postoperative pain 
management remains a challenge in low-resource centres partly due to the failure of 
functional narcotic supply systems.2,3 In our centre, problems with supply often restrict 
us to the use of tramadol or pentazocine for severe postoperative pain that usually 
follows mastectomy. Thoracic paravertebral block (TPVB) has been shown to provide 
prolonged postoperative pain relief for unilateral breast operations. 4,5 Consequently, 
our team began performing single-shot TPVB using the new lamina approach as an 
adjunct to general anaesthesia (GA) for major breast surgery.6 To the best of our 
knowledge, no study has investigated the effectiveness of single-shot lamina TPVB. In 
this pilot study, we investigated the postoperative analgesic effect of single-shot TPVB 
following modified radical mastectomy with axillary clearance by assessing the time to 
the first request for analgesic, quantified the total analgesic (opioid and non-opioid) 
consumption (in mg), and assessed postoperative pain scores over 72 h in patients with 
or without TPVB. 
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Patients and Methods 
Approval for the study was obtained from Oyo State Ethical Review Committee. We 
reviewed data (anaesthetic charts, recovery room and ward records) collected during 
routine clinical management of 31 consecutive ASA physical status 1 and 2 female 
patients who had unilateral modified radical mastectomy with axillary dissection under 
GA with or without TPVB. Although the study period was 13/03/2014 to 12/05/2015, 
clinical work was disrupted over 7 months owing to industrial action by health workers 
which affected the number of patients operable. Each patient was instructed in the 
verbal rating scale (VRS) in vernacular validated by Soyannwo et al, as the pain 
assessment tool before the procedure; 0 = no pain (kosiirora), 1 = mild pain (irora die), 
2 = discomforting pain (irora ti o ninilara), 3 = distressing pain (irora ti o banilokan je), 
4 = horrible pain (irora ti o ga), 5 = excruciating pain (irora ti o kojaifarada).7 
 
Exposures to TPVB were based on the availability of equipment and the anaesthetist to 
perform the procedure (all the TPVB were performed by the leading investigator). Each 
patient gave written, informed consent for the anaesthetic technique employed. We 
compared the time to first request for pain relief between both groups (timed from the 
completion of surgery), pain scores and total analgesic (opioid and non-opioid) 
consumption (in mg) for the first 72 h. The VRS charts were kept in the recovery room 
and ward at 2 h, 4 h, 6 h, 8 h, 12 h, 24 h, 36 h, 48 h, 60 h and 72 h. Every patient received 
IV injection of pentazocine 30 mg at induction of GA. Postoperatively, patients rated 
their pain using the VRS scale, if 1 or 2 received paracetamol and if analgesia was 
inadequate, diclofenac was added; if VRS score ≥ 3/5 pentazocine or tramadol and 
paracetamol were administered and if analgesia was inadequate, diclofenac was added.  
There was no premedication given to the patients. The preoperative fasting guideline 
observed was solid food 6 h and clear fluids 2 h before surgery. In the operating room, 
intravenous (IV) access was established with an 18G cannula on the non-dominant arm 
and 500 mL of normal saline solution setup. Monitoring consisted of noninvasive blood 
pressure, electrocardiography, pulse oximetry and the heart rate using the Classic-120 
Multiparameter® monitor (Health-Care Equipment and Supplies Co. Ltd, Egham, 
Surrey, UK). Each patient’s baseline vital signs comprising heart rate, blood pressure 
and arterial oxygen saturation (SaO2) while breathing room air was measured and 
recorded. 
 
The lamina approach used in this study was Juttner et al’s modification of Pfeiffer et al’s 
technique.8,9 Each TPVB patient was placed in the sitting position on the operating table 
and C7-T6 vertebral spinous processes were palpated and marked. The scapular spine 
was palpated and identified as a landmark for T3 vertebral spinous process. Thereafter 
1.5 cm from the midline on the side to be blocked was marked as the needle entry point. 
Skin preparation was done with 10% povidone iodine solution and draped. This 
injection site was infiltrated with 2-3 mL 2% lidocaine with 1:200,000 epinephrine and 
a 16G Tuohy needle (Perifix, B. Braun, Melsungen, Germany) was inserted and advanced 
in a paramedian sagittal plane at 45° to the skin in the cranial direction using loss of 
resistance to air technique with a 20 mL syringe until contact was made with the 
vertebral lamina usually at a depth of 4-6 cm. After negative aspiration of air,  
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cerebrospinal fluid or blood, 6 mL 2% lidocaine with 1:200,000 epinephrine was 
injected, followed by the insertion of 18G catheter (Perifix, B. Braun, Melsungen, 
Germany) 3.0 cm beyond the needle tip. This step (epidural catheter insertion) was 
necessary to enter the paravertebral space after making contact with the vertebral 
lamina even in single-shot technique. After securing the catheter, 5 mL 2% lidocaine 
with 1:200,000 epinephrine was administered as a test dose while monitoring the 
patient’s pulse rate, blood pressure and consciousness to exclude epidural or 
subarachnoid injection or pneumothorax. Thereafter, 20 mL 0.5% isobaric bupivacaine 
with 1:200,000 epinephrine was injected over 5 min. We did not wait to test the block 
but placed the patient supine on the operating table for the induction of GA. Each 
catheter was removed after surgery in the recovery room.  
 
Every patient received IV pentazocine 30 mg before induction with propofol 1.5-2.0 
mg/kg IV and pancuronium 0.1 mg/kg IV was administered to facilitate tracheal 
intubation. Anaesthesia was maintained with isoflurane in oxygen and incremental 
doses of pancuronium 0.01 mg/kg. At the completion of surgery, neostigmine 2.5 mg 
and atropine 1.2 mg was administered IV to reverse the residual neuromuscular block 
followed by extubation when the criteria indicating full recovery from anaesthesia were 
met, such as, SaO2 above 95%, regular breathing, full wakefulness and obeying 
commands. Next, the patient was transferred to the postanaesthesia care unit (PACU) 
for observation for 1 hour. The data was analysed using the statistical package for the 
social sciences (SPSS for windows 17.0, SPSS Inc., Chicago, IL, USA).  The analysis 
included descriptive statistics such as frequencies, percentages, and inferential statistics 
such as student t-, Mann-Whitney U and Fisher’s exact tests. A P-value of <0.05 was 
considered statistically significant. 
 
Results 
Sixteen patients had TPVB but in one of them, epidural catheter (20G) insertion failed 
and there was request for rescue analgesic 40 min postoperatively (VRS 4/5). The block 
was judged to have failed and she was excluded from the TPVB cohort.  
 
Table 1: Demographic profile of patients 
Variables TPVB Group 
(n=15) 
No-block Group 
(n=15) 
P 
value 
Age (year) 51.6 ± 10.4 51.1 ± 12.7 0.91 
Weight (kg) 66.5 ± 10.5 75.1 ± 8.7 0.02 
Height (cm) 160.6 ± 4.3 164.1 ± 3.7 0.02 
BMI (kg/m2) 25.9 ± 4.7 27.9 ± 2.9 0.19 
ASA I/II (n) 7/8 5/10  
Duration of surgery (min) 141.2 ± 33.4 129.5 ± 27.7  
Hospitalisation period 
(days) 
10.9 ± 3.0 11.6 ± 3.0 0.51 
Data are numbers and mean values (standard deviation). 
The two groups were similar in age, BMI, duration of surgery and hospitalisation (Table 
1) excepting the fact that TPVB patients weighed less and were shorter (p=0.02).  
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The pain scores (VRS) in the recovery room was significantly lower in the TPVB group 
at all measurement points as shown in Table 2.  
 
Table 2: Recovery room postoperative pain (VRS) scores for the two groups  
Time (min) TPVB Group (n=15) No-block Group (n=15) P value 
10 0.00 (0.00-0.38) 3.00 (2.00-3.25) 0.0001 
20 0.00 (0.00-0.40) 3.00 (2.00-3.00) 0.0001 
30 0.00 (0.00-0.00) 3.00 (1.00-3.00) 0.0001 
40 0.00 (0.00-0.00) 3.00 (2.00-3.00) 0.0001 
50 0.00 (0.00-0.00) 3.00 (2.00-3.00) 0.0001 
60 0.00 (0.00-0.00) 3.00 (2.00-3.25) 0.0001 
Data are median values (interquartile range) 
The VRS pattern continued in the ward until the 24 h mark when there was no 
significant difference (Table 3). 
Figure 1: Boxplot for time to first analgesic request after surgery in minutes by 
group 
Table 3: Postoperative pain (VRS) score on the ward for the two groups  
Time (h) TPVB Group (n=15) No-block Group (n=15) P value 
2 0.00 (0.00-0.00) 2.00 (2.00-3.00) 0.0001 
4 0.00 (0.00-0.25) 2.00 (2.00-3.00) 0.017 
6 0.00 (0.00-1.00) 2.00 (2.00-3.00) 0.0001 
8 0.00 (0.00-1.00) 2.00 (2.00-3.00) 0.001 
12 0.00 (0.00-1.00) 2.00 (2.00-3.00) 0.044 
24 0.50 (0.00-2.00) 2.00 (2.00-3.00) 0.100 
36 1.00 (0.25-1.75) 2.00 (2.00-3.00) 0.047 
48 1.00 (1.00-1.75) 2.00 (2.00-2.00) 1.000 
60 1.00 (1.00-2.00) 2.00 (2.00-2.00) 1.000 
72 1.50 (1.00-2.00) 2.00 (1.00-2.00) 1.000 
Data are median values (interquartile range) 
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No patient in the TPVB group required rescue analgesic during the 1 h recovery room 
stay compared with 5 (33.3%) patients in the no-block group, p=0.04. The median time 
to first request for analgesic was 43 h (25.2-73.0 h) in the block group versus 2 h (1.0-
2.5 h) in the no-block group, p=0001. This difference is shown in Fig 1. 
Discussion 
Postoperative pain of moderate-to-severe intensity after major breast surgery for 
cancer remains a clinical problem in resource-poor settings with under-treatments 
associated with increased morbidity.10 Our results indicated that single-shot TPVB using 
0.5% bupivacaine with 1:200,000 epinephrine provided prolonged postoperative 
analgesia, less need for opioid and non-opioid analgesics in patients treated with 
modified radical mastectomy and axillary clearance for breast cancer compared  with 
patients who had no block. The high success rate (94%) in our small cohort is 
congruous with the Düsseldorf study (98%) indicating that the lamina technique might 
produce less failed blocks compared to the classical approach where about 13-27.3% 
failure rate has been reported.11-13 The failure we recorded due to the difficulty with 
20G catheter insertion was not unexpected, it is easier to tunnel larger-caliber catheters 
through the superior costotransverse ligament into the thoracic paravertebral space.8 
 
Our results of optimal pain control with TPVB are in agreement with the findings of 
previous studies which showed that TPVB was an effective option for postoperative 
analgesia and its use obviated the need for epidural block as well as systemic opioids 
thereby avoiding side effects associated with these therapeutic modalities.5,8,14,15 TPVB 
patients reported less pain than their no-block counterparts; there was significant 
difference in the VRS until 24 h postoperatively. The pain relief was so profound that no 
patient in the TPVB group required opioid and non-opioid analgesic within 24 h. This 
observation differs from results of single-shot multi-level TPVBs in which significant 
differences in pain scores, opioid analgesic consumption lasted 6-8 h.16,17Our 
explanation for this difference is that in the lamina TPVB technique, the catheter that is 
tunneled into the TPVS allows the injection of a higher LA volume which engenders a 
better cranio-caudal spread than the multi-level classical approach. The opioid-sparing 
effect of TPVB is desirable in cancer for perioperative anaesthesia/ analgesia because 
opioids promote angiogenesis, tumor cell proliferation and metastasis. Regional 
anaesthesia attenuates cell-mediated immunosuppression and local anaesthetic agents 
block voltage-gated sodium channels that malignant cells require for growth and 
spread.18-20 
 
We believe that our results are important in our low-resource setting because they 
show that single-shot lamina TPVB provided optimal pain relief. We acknowledge that 
the small cohort of patients studied and the lack of randomization with selection bias 
may be limitations, so we are cautious in the interpretation of our results which suggest 
that the lamina TPVB is effective and probably easier to perform than the classical 
TPVB. Our failure to take into account the different stages of the resected breast 
carcinomas as well as co-existing medical conditions meant that obvious confounding 
variables were not excluded. In view of the small number of study patients, the power 
calculation to detect difference in the tramadol consumption was 95%. Prospective 
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randomised studies with large patient population are required to confirm if lamina 
TPVB have high success rate and effectiveness as these early results suggest. 
Conclusion 
 
Single-shot lamina TPVB technique provided prolonged postoperative analgesia, and 
reduced opioid and non-opioid consumption. 
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